Claim
quantitative

Statins cause a very small rise in average blood sugar levels—about 0.06% in HbA1c and 0.04 mmol/L in glucose—which is too minor to be noticed by individuals but enough to push some people over the diabetes diagnostic threshold.

Evidence from Studies

No evidence studies found yet.

What Would Prove This

Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.

1
Systematic Reviews & Meta-Analyses
In Evidence

This meta-analysis itself provides the highest-level evidence for the magnitude of statin-induced glycaemic shifts across diverse populations and statin types.

This study is already the ideal systematic review: pooling individual-level glucose and HbA1c measurements from 23 RCTs with standardized assays and follow-up timing.

2
Randomized Controlled Trials

An RCT could confirm the exact magnitude of HbA1c and glucose rise from specific statin doses in a controlled setting with frequent measurements.

A double-blind RCT of 500 adults aged 50–70 without diabetes, randomized to high-intensity atorvastatin 80mg, moderate-intensity rosuvastatin 20mg, or placebo, with HbA1c and fasting glucose measured monthly for 2 years.

3
Cohort Studies

Could quantify the real-world average HbA1c rise in statin users over time compared to non-users, adjusting for confounders.

A prospective cohort of 15,000 adults aged 45–75 with baseline HbA1c <5.7%, followed for 5 years, with annual HbA1c measurements, tracking statin initiation and dose, adjusting for BMI, diet, and physical activity.

4
Case-Control Studies

Could compare the magnitude of HbA1c rise in statin users who developed diabetes versus those who did not.

A case-control study of 1,000 statin users who developed diabetes and 2,000 who did not, comparing the mean change in HbA1c from baseline to diagnosis or last follow-up.

5
Cross-Sectional Studies

Could show a correlation between statin use and current HbA1c levels, but cannot determine direction or change over time.

A cross-sectional analysis of 10,000 adults in primary care, comparing mean HbA1c levels between statin users and non-users at a single time point.

Sign up to see full verdict